Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.
Jul 15, 2026
0
6
The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was generally well tolerated in infected volunteers, showing it is a promising candidate for uncomplicated ...
Jul 15, 2026
0
6
Scientists have identified genetic changes in wild populations of the parasitic worm that causes schistosomiasis that may reduce its response to praziquantel, the only available treatment. The study provides an early warning ...
Jul 17, 2026
0
6
A review article by a University of Nebraska Medical Center/Child Health Research Institute research team underscores how altering fundamental brain development processes can harm the developing fetus. The publication suggests ...
Jul 20, 2026
0
6
New research from VCU Massey Comprehensive Cancer Center provides evidence for a combination treatment strategy that uses cells' waste-removal functions to target multiple myeloma. The findings, published recently in Cell ...
Jul 14, 2026
0
5
Dietary supplements must be better regulated to protect public health, says the American College of Physicians (ACP). In a new paper, "Modernizing the Regulatory Framework for Dietary Supplements: A Position Paper from the ...
Jul 14, 2026
0
5
Wearable devices have transformed how people track exercise, sleep, heart rate and other vital signs. Researchers at King Abdullah University of Science and Technology (KAUST) are now exploring whether similar technologies ...
Jul 14, 2026
0
5
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 ...
Jul 20, 2026
0
5
A study by researchers at Kent has revealed that the narcotic analgesic tapentadol has performance-enhancing effects on cyclists, making this drug a candidate for addition to the World Anti-Doping Agency's (WADA) list of ...
Jul 16, 2026
0
5
People taking semaglutide for weight loss continued to consume significantly fewer calories after 60 weeks on the medication, helping explain how the medication supports both initial weight loss and long-term weight maintenance. ...
Jul 21, 2026
0
5
